1、 Jennifer Gill,Aurelio Miracolo,Konstantina Politopoulou,Sahan Jayawardana,Alex Carter,Efstratios Apostolou and Panos Kanavos January 2024 How can we Improve Secondary Prevention of Cardiovascular Disease?Please cite this study as:Jennifer Gill,Aurelio Miracolo,Konstantina Politopoulou,Sahan Jayawar

2、dana,Alex Carter,Efstratios Apostolou and Panos Kanavos 2024.How can we Improve Secondary Prevention of Cardiovascular Disease?London School of Economics and Political Science.DOI https:/doi.org/10.21953/lse.f81e9y7znju1 by Jennifer Gill,Aurelio Miracolo,Konstantina Politopoulou,Sahan Jayawardana,Al

3、ex Carter,Efstratios Apostolou and Panos Kanavos.This report is commissioned via LSE Consulting which was set up by The London School of Economics and Political Science to enable and facilitate the application of its academic expertise and intellectual resources.LSE Enterprise Ltd,trading as LSE Con

4、sulting,is a wholly owned subsidiary of the London School of Economics and Political Science.The LSE trademark is used under licence from the London School of Economics and Political Science.LSE Consulting LSE Enterprise Ltd London School of Economics and Political Science Houghton Street London,WC2

5、A 2AE (T)+44(0)20 7106 1198(E)consultinglse.ac.uk (W)lse.ac.uk/consultancy How can we Improve Secondary Prevention of CVD?Acknowledgements This research has received financial support from the European Federation of Pharmaceutical Industries and Associations(EFPIA)Cardiovascular Health Platform.The

6、authors are grateful to EFPIA and their member representatives for their helpful input and support during the development of this report.The authors extend their gratitude to the cardiovascular experts who provided their insights and expertise during the development of this report:Prof.Francesco Cos